MD3680243T2 - Compus pentaciclic - Google Patents

Compus pentaciclic

Info

Publication number
MD3680243T2
MD3680243T2 MDE20200725T MDE20200725T MD3680243T2 MD 3680243 T2 MD3680243 T2 MD 3680243T2 MD E20200725 T MDE20200725 T MD E20200725T MD E20200725 T MDE20200725 T MD E20200725T MD 3680243 T2 MD3680243 T2 MD 3680243T2
Authority
MD
Moldova
Prior art keywords
pentacyclic compound
pentacyclic
compound
formulas
pharmaceutically acceptable
Prior art date
Application number
MDE20200725T
Other languages
English (en)
Inventor
Yoshiaki Ohashi
Yoshihiko Norimine
Tamaki HOSHIKAWA
Yu Yoshida
Yoshihisa Kobayashi
Nobuhiro Sato
Koji Hagiwara
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MD3680243T2 publication Critical patent/MD3680243T2/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Prezenta invenţie oferă compuşi reprezentaţi de formulele (I)-(VI) sau săruri acceptabile din punct de vedere farmaceutic ale acestora:
MDE20200725T 2017-09-07 2018-09-05 Compus pentaciclic MD3680243T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017172169 2017-09-07
PCT/JP2018/032797 WO2019049869A1 (ja) 2017-09-07 2018-09-05 五環式化合物

Publications (1)

Publication Number Publication Date
MD3680243T2 true MD3680243T2 (ro) 2022-05-31

Family

ID=65517037

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20200725T MD3680243T2 (ro) 2017-09-07 2018-09-05 Compus pentaciclic

Country Status (33)

Country Link
US (1) US10239889B1 (ro)
EP (1) EP3680243B1 (ro)
JP (1) JP6557441B1 (ro)
KR (1) KR102307738B1 (ro)
CN (1) CN111051316B (ro)
AR (1) AR112788A1 (ro)
AU (1) AU2018330578B2 (ro)
BR (1) BR112020003197A2 (ro)
CA (1) CA3072740A1 (ro)
CL (1) CL2020000376A1 (ro)
CO (1) CO2020001471A2 (ro)
CY (1) CY1125355T1 (ro)
DK (1) DK3680243T3 (ro)
ES (1) ES2903172T3 (ro)
HR (1) HRP20220019T1 (ro)
HU (1) HUE056791T2 (ro)
IL (1) IL272652B (ro)
JO (1) JOP20200030A1 (ro)
LT (1) LT3680243T (ro)
MA (1) MA50093B1 (ro)
MD (1) MD3680243T2 (ro)
MX (1) MX2020001786A (ro)
PH (1) PH12020500341A1 (ro)
PL (1) PL3680243T3 (ro)
PT (1) PT3680243T (ro)
RS (1) RS62796B1 (ro)
RU (1) RU2754557C1 (ro)
SG (1) SG11202001240XA (ro)
SI (1) SI3680243T1 (ro)
TW (1) TWI707859B (ro)
UA (1) UA125940C2 (ro)
WO (1) WO2019049869A1 (ro)
ZA (1) ZA202000970B (ro)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020533317A (ja) 2017-09-07 2020-11-19 オーガスタ ユニバーシティ リサーチ インスティテュート,インコーポレーテッド 特異的akt3活性化剤およびその使用
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
WO2020179781A1 (ja) * 2019-03-05 2020-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 五環式化合物の塩およびそれらの結晶
JPWO2020179780A1 (ro) 2019-03-05 2020-09-10
WO2021113492A1 (en) * 2019-12-06 2021-06-10 Schrödinger, Inc. Cyclic compounds and methods of using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187306A (en) * 1977-07-26 1980-02-05 Bayer Aktiengesellschaft Benzodiazepine-diones, a process for their production and their use as medicaments
DD258234A1 (de) * 1987-03-05 1988-07-13 Univ Leipzig Verfahren zur herstellung von pyrido/3',2':4,5/thieno/2,3-e/imidazo-/1,2-c/pyrimidinen sowie strukturanaloger -pyrimido/1,2-c/pyrimidine bzw. -1,3-diazepino/1,2-c/pyrimidine
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
TW197442B (ro) * 1990-02-08 1993-01-01 Pfizer
KR100203456B1 (ko) * 1995-06-20 1999-06-15 한승수 디하이드로에보디아민-에이치씨1를 유효성분으로 함유하는 알츠하이머병에 의한 치매 치료제
FR2779652B1 (fr) * 1998-06-15 2001-06-08 Sod Conseils Rech Applic Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
JP4751398B2 (ja) * 2004-10-20 2011-08-17 エフ.ホフマン−ラ ロシュ アーゲー ハロゲン置換ベンゾジアゼピン誘導体
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
US8192080B2 (en) 2007-01-23 2012-06-05 Tsi Technologies Llc Microwire-controlled autoclave and method

Also Published As

Publication number Publication date
ES2903172T3 (es) 2022-03-31
PL3680243T3 (pl) 2022-02-14
JOP20200030A1 (ar) 2020-02-12
MA50093A (fr) 2021-05-05
CN111051316B (zh) 2022-05-31
CL2020000376A1 (es) 2020-08-28
EP3680243A4 (en) 2021-01-06
IL272652A (en) 2020-03-31
CO2020001471A2 (es) 2020-05-29
HRP20220019T1 (hr) 2022-04-01
JP6557441B1 (ja) 2019-08-07
RS62796B1 (sr) 2022-02-28
HUE056791T2 (hu) 2022-03-28
CY1125355T1 (el) 2024-02-16
MX2020001786A (es) 2022-09-13
EP3680243A1 (en) 2020-07-15
RU2754557C1 (ru) 2021-09-03
AR112788A1 (es) 2019-12-11
BR112020003197A2 (pt) 2020-09-29
US20190071452A1 (en) 2019-03-07
JPWO2019049869A1 (ja) 2019-11-07
TWI707859B (zh) 2020-10-21
PH12020500341A1 (en) 2020-10-05
IL272652B (en) 2022-09-01
EP3680243B1 (en) 2021-10-27
AU2018330578A1 (en) 2020-02-27
CN111051316A (zh) 2020-04-21
LT3680243T (lt) 2021-11-25
UA125940C2 (uk) 2022-07-13
KR102307738B1 (ko) 2021-10-05
DK3680243T3 (da) 2022-01-10
KR20200051585A (ko) 2020-05-13
AU2018330578B2 (en) 2022-11-10
ZA202000970B (en) 2021-07-28
SG11202001240XA (en) 2020-03-30
TW201920195A (zh) 2019-06-01
MA50093B1 (fr) 2022-05-31
SI3680243T1 (sl) 2022-01-31
PT3680243T (pt) 2022-01-12
WO2019049869A1 (ja) 2019-03-14
US10239889B1 (en) 2019-03-26
CA3072740A1 (en) 2019-03-14

Similar Documents

Publication Publication Date Title
MD3680243T2 (ro) Compus pentaciclic
PH12018500177A1 (en) Compositions useful for treating disorders related to kit and pdfgr
CR20170573A (es) Lactamas bicíclicas y métodos de uso de las mismas
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
EA201792021A1 (ru) Ингибитор jak
MD3464249T2 (ro) Derivați carbonucleozidici substituiţi utili în calitate de agenți anticanceroşi
EA201790407A1 (ru) Зонды для визуализации белка хантингтина
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
MY177574A (en) New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
PH12020500655A1 (en) Compounds
EA201791684A1 (ru) Селективные ингибиторы bace1
DK3386991T3 (da) Polycykliske forbindelser som inhibitorer af bruton's tyrosinkinase
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
EA201790400A1 (ru) Зонды для визуализации белка хантингтина
MX2019013979A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
MX2018007219A (es) Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.
EA201690523A1 (ru) Триазолопиридины, композиции и способы их применения
EA201792425A1 (ru) Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз
CY1123406T1 (el) Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας
ECSP21088515A (es) Compuestos de pirrolidina
EA201891431A1 (ru) Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина
BR112018006005A2 (pt) composto bicíclico e uso do mesmo para inibição de suv39h2
MX2019008375A (es) Tiobenzoimidazol como fungicidas.